Gotowa bibliografia na temat „Selenoprote”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Selenoprote”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Selenoprote"
Mahmoud, Kholoud Gamal, Rasha Mohamed Gamal Elshafiey, Radwa Mahmoud Elsharaby i Amany Mahmoud Elbarky. "Selenoprotein-p as Biomarker of Selenium Status in Obese Children and Adolescents". Asian Journal of Pediatric Research 13, nr 4 (21.12.2023): 169–79. http://dx.doi.org/10.9734/ajpr/2023/v13i4306.
Pełny tekst źródłaZhang, Chi, i Qi Bin Huang. "A Preliminary Study on the Antioxidant Activity of Selenoprotein in Cordyceps militaris Rich in Selenium". Advanced Materials Research 396-398 (listopad 2011): 157–61. http://dx.doi.org/10.4028/www.scientific.net/amr.396-398.157.
Pełny tekst źródłaLu, Zhuang, Pengzu Wang, Teng Teng, Baoming Shi, Anshan Shan i Xin Gen Lei. "Effects of Dietary Selenium Deficiency or Excess on Selenoprotein Gene Expression in the Spleen Tissue of Pigs". Animals 9, nr 12 (11.12.2019): 1122. http://dx.doi.org/10.3390/ani9121122.
Pełny tekst źródłaBurk, R. F., K. E. Hill, R. Read i T. Bellew. "Response of rat selenoprotein P to selenium administration and fate of its selenium". American Journal of Physiology-Endocrinology and Metabolism 261, nr 1 (1.07.1991): E26—E30. http://dx.doi.org/10.1152/ajpendo.1991.261.1.e26.
Pełny tekst źródłaSquires, Jeffrey E., Ilko Stoytchev, Erin P. Forry i Marla J. Berry. "SBP2 Binding Affinity Is a Major Determinant in Differential Selenoprotein mRNA Translation and Sensitivity to Nonsense-Mediated Decay". Molecular and Cellular Biology 27, nr 22 (10.09.2007): 7848–55. http://dx.doi.org/10.1128/mcb.00793-07.
Pełny tekst źródłaWhanger, P. D. "Selenoprotein expression and function—Selenoprotein W". Biochimica et Biophysica Acta (BBA) - General Subjects 1790, nr 11 (listopad 2009): 1448–52. http://dx.doi.org/10.1016/j.bbagen.2009.05.010.
Pełny tekst źródłaHayek, Hassan, Gilbert Eriani i Christine Allmang. "eIF3 Interacts with Selenoprotein mRNAs". Biomolecules 12, nr 9 (9.09.2022): 1268. http://dx.doi.org/10.3390/biom12091268.
Pełny tekst źródłaSunde, Roger A., Anna M. Raines, Kimberly M. Barnes i Jacqueline K. Evenson. "Selenium status highly regulates selenoprotein mRNA levels for only a subset of the selenoproteins in the selenoproteome". Bioscience Reports 29, nr 5 (25.06.2009): 329–38. http://dx.doi.org/10.1042/bsr20080146.
Pełny tekst źródłaFatoki, Toluwase Hezekiah, Omodele Ibraheem, Amos Olalekan Abolaji i David Morakinyo Sanni. "In Silico study of anticarcinogenic potential of the selenoprotein BthD from Drosophila melanogaster. Identifying the anticancer peptide CRSUR from the conserved region". Nova Biotechnologica et chimica 19, nr 1 (30.06.2020): 37–51. http://dx.doi.org/10.36547/nbc.v19i1.576.
Pełny tekst źródłaUrbano, Teresa, Marco Vinceti, Jessica Mandrioli, Annalisa Chiari, Tommaso Filippini, Roberta Bedin, Manuela Tondelli i in. "Selenoprotein P Concentrations in the Cerebrospinal Fluid and Serum of Individuals Affected by Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment and Alzheimer’s Dementia". International Journal of Molecular Sciences 23, nr 17 (30.08.2022): 9865. http://dx.doi.org/10.3390/ijms23179865.
Pełny tekst źródłaRozprawy doktorskie na temat "Selenoprote"
Ferreira, Diana Quit?ria Cabral. "Avalia??o do estado nutricional relativo ao sel?nio e da express?o g?nica de selenoprote?nas em pacientes com aterosclerose tratados com estatinas". Universidade Federal do Rio Grande do Norte, 2010. http://repositorio.ufrn.br:8080/jspui/handle/123456789/13489.
Pełny tekst źródłaConselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
The aim of this study was to determine the effects of the use of rosuvastatin in patients with atherosclerosis, in relation to blood parameters of selenium and selenoproteins, and also observe possible changes in gene expression of selenoproteins in these patients. The sample consisted of 27 adult and elderly patients with a clinical diagnosis of coronary artery disease undergoing angioplasty, treated at Natal Hospital Center hospital, Natal, RN. Patients were treated with rosuvastatin 10 mg/day during four months. Anthropometric variables such as body mass index (BMI) and Waist circumference (WC) were measured before and after treatment, as well as lipid profile, blood glucose and liver enzymes (AST and ALT). The diet of the patients was also analyzed using 24-hour diet recall. We analyzed the concentrations of selenium in plasma and erythrocytes, and also the activity of Glutathione Peroxidase and gene expression by Real Time PCR of selenoproteins GPx1, SelP1 and SelN1. Patients had mean age of 61.0 ? 9.4 years, 59.3% were men and 40.7% were women. After four months of treatment there was significant reduction of CA and, according to BMI, most were overweight. The intake of macronutrients, cholesterol, polyunsaturated fatty acids, monounsaturated and saturated was adequate, but the energy and fiber intake was below the recommendations. Regarding the selenium intake was observed a high prevalence of inadequacy. As expected, after treatment with rosuvastatin, a significant reduction in total cholesterol, LDL and glucose, which was not observed for HDL. Selenium concentrations in plasma and erythrocytes showed no changes, keeping within the established cutoffs. We observed a significant increase in GPx enzyme activity and mRNA expression of GPX1 and SEPN1, but not for gene SEPP1. Thus, it was found that treatment with rosuvastatin did not reduce the expression of selenoproteins. More studies are needed to clarify the effects of rosuvastatin on gene expression of selenoproteins in patients with atherosclerosis
Este trabalho tem como objetivo verificar os efeitos do uso da rosuvastatina em pacientes com aterosclerose, em rela??o aos par?metros sangu?neos de sel?nio e selenoprote?nas, bem como observar poss?veis altera??es na express?o g?nica de selenoprote?nas nesses pacientes. A amostra foi constitu?da de 27 pacientes adultos e idosos com o diagn?stico cl?nico de doen?a arterial coronariana submetidos ? angioplastia, atendidos no Natal Hospital Center, Natal, RN. Os pacientes foram tratados com 10mg/dia de rosuvastatina durante 4 meses. Vari?veis antropom?tricas, como ?ndice de Massa Corporal (IMC) e Circunfer?ncia Abdominal (CA), foram medidas antes e ap?s o tratamento, bem como o perfil lip?dico, glicemia e enzimas hep?ticas (AST e ALT). A dieta dos pacientes tamb?m foi analisada utilizando o Recordat?rio alimentar de 24 horas. Foram analisadas as concentra??es do sel?nio no plasma e nos eritr?citos, e tamb?m a atividade da enzima Glutationa Peroxidase e a express?o g?nica por PCR em Tempo Real das selenoprote?nas GPx1, SelP1 e SelN1. Os pacientes apresentaram idade m?dia de 61,0?9,4 anos, sendo 59,3% homens e 40,7% mulheres. Ap?s os quatro meses de tratamento observou-se redu??o significativa da CA e, de acordo com o IMC, a maior parte estava com sobrepeso. A ingest?o dos macronutrientes, colesterol, ?cidos graxos polinsaturados, monoinsaturados e saturados foi adequada, por?m a de energia e fibras estava abaixo das recomenda??es. Com rela??o a ingest?o de sel?nio foi observada uma alta preval?ncia de inadequa??o. Como esperado, ap?s o tratamento com a rosuvastatina, houve redu??o significativa do colesterol total e LDL, bem como da glicemia, o que n?o foi observado para o HDL. As concentra??es de sel?nio no plasma e eritr?citos n?o apresentaram altera??es, se mantendo dentro dos pontos de corte estabelecidos. Foi observado um aumento significante na atividade enzim?tica da GPx e na express?o de mRNA do GPX1 e SEPN1, mas n?o para o gene SEPP1. Dessa forma, foi verificado que o tratamento com a rosuvastatina n?o diminuiu a express?o das selenoprote?nas. Mais estudos s?o necess?rios para esclarecer os efeitos da rosuvastatina sobre a express?o g?nica de selenoprote?nas em pacientes com aterosclerose
Rida, Ahmad. "Biochemical and structural characterization of Selenoprotein N and study of his dysfunction in pancreatic tissue". Electronic Thesis or Diss., Strasbourg, 2023. http://www.theses.fr/2023STRAJ128.
Pełny tekst źródłaIn humans, mutations in the SELENON gene, encoding selenoprotein N (SelenoN), cause a group of inherited muscular disorders termed SELENON-related myopathies. The pathogenic mechanisms behind these muscular diseases are poorly understood since the catalytic function of SelenoN remains elusive. The use of animal models revealed the importance of SelenoN in muscle development, maintenance, and regeneration. Moreover, SelenoN has been shown to play a role in oxidative stress control in the endoplasmic reticulum and maintenance of calcium homeostasis in the cell, as well as a link with mitochondrial function. Despite these exciting progresses regarding the physiological involvement of SelenoN in muscle tissue, the catalytic activity of this enzyme is still unknown, and no treatment is available. This project aims to develop in vitro and in vivo studies to characterize SelenoN enzymatic activity and the molecular and cellular context of this activity. Firstly, we were able to express and purify pure and soluble recombinant form of SelenoN. Analysis showed that SelenoN binds a small molecule, currently under characterization. The resolution of SelenoN 3D structure provided new insight and understanding of the catalytic site of the protein. In parallel, SelenoN cellular environment and partners were investigated using proximal labeling (BioID) in cellulo, showing a specific localization within the endoplasmic reticulum, related to protein folding and ER stress response. Finally, in vivo using SelenoN-/-mice model demonstrated a gender specific metabolic phenotype. These integrative studies provided key information about the molecular and physio-pathological basis of SELENON-related myopathies and will pave the way for therapy development
Rother, Michael. "Selenoprotein-Biosynthese in Archaea". Diss., lmu, 2002. http://nbn-resolving.de/urn:nbn:de:bvb:19-680.
Pełny tekst źródłaTobe, Ryuta. "Enzymological studies on selenoprotein biosynthesis". Kyoto University, 2009. http://hdl.handle.net/2433/126536.
Pełny tekst źródła0048
新制・課程博士
博士(農学)
甲第14875号
農博第1787号
新制||農||975(附属図書館)
学位論文||H21||N4490(農学部図書室)
27297
UT51-2009-K671
京都大学大学院農学研究科応用生命科学専攻
(主査)准教授 栗原 達夫, 教授 渡邊 隆司, 教授 阪井 康能
学位規則第4条第1項該当
Eussner, Ursula. "Selenoprotein P in der kolorektalen Karzinogenese". [S.l.] : [s.n.], 2003. http://deposit.ddb.de/cgi-bin/dokserv?idn=967777690.
Pełny tekst źródłaCrosley, L. K. "Molecular mechanisms of selenoprotein gene expression". Thesis, University of Newcastle Upon Tyne, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.399315.
Pełny tekst źródłaCockman, Eric Michael. "Post-Transcriptional Regulation of Selenoprotein S". Case Western Reserve University School of Graduate Studies / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=case1562593531805034.
Pełny tekst źródłaVillette, Stephane. "Molecular study of selenoprotein in gene expression". Thesis, University of Newcastle Upon Tyne, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.391327.
Pełny tekst źródłaMiller, Susan Mary. "Selenoprotein function and expression in human endothelium". Thesis, University of Edinburgh, 2000. http://hdl.handle.net/1842/23124.
Pełny tekst źródłaPagmantidis, Vasileios. "Selenoprotein gene expression and susceptibility to colon cancer". Thesis, University of Newcastle Upon Tyne, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.413956.
Pełny tekst źródłaKsiążki na temat "Selenoprote"
Selenoprotein Structure and Function. Elsevier, 2022. http://dx.doi.org/10.1016/s0076-6879(22)x0002-5.
Pełny tekst źródłaWeerapana, Eranthie. Selenoprotein Structure and Function. Elsevier Science & Technology, 2022.
Znajdź pełny tekst źródłaWeerapana, Eranthie. Selenoprotein Structure and Function. Elsevier Science & Technology Books, 2022.
Znajdź pełny tekst źródłaYeh, Jan-ying. The influence of selenium on selenoprotein W. 1995.
Znajdź pełny tekst źródłaSun, Yu. Selenoprotein W: Distribution and function in rat tissue and cultured cells. 1998.
Znajdź pełny tekst źródłaKrehl, Susanne. Das Selenoprotein Glutathionperoxidase-2: Physiologische Funktion und Einfluss auf die entzündungsassoziierte Colonkarzinogenese. 2011.
Znajdź pełny tekst źródłaCzęści książek na temat "Selenoprote"
Hill, Kristina E., i Raymond F. Burk. "Selenoprotein P". W Selenium, 123–35. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1609-5_11.
Pełny tekst źródłaReeves, Mariclair A., i Marla J. Berry. "Selenoprotein M". W Selenium, 197–203. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1025-6_15.
Pełny tekst źródłaSaito, Yoshiro, i Kazuhiko Takahashi. "Selenoprotein P". W Advanced Topics in Science and Technology in China, 77–88. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-22236-8_5.
Pełny tekst źródłaTanguy, Yannick, Sébastien Arthaud, Anthony Falluel-Morel, Destiny-Love Manecka, Abdeslam Chagraoui, Isabelle Lihrmann i Youssef Anouar. "Selenoprotein T". W Advanced Topics in Science and Technology in China, 89–95. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-22236-8_6.
Pełny tekst źródłaKim, Ick Young, i Daewon Jeong. "Selenoprotein W". W Advanced Topics in Science and Technology in China, 97–105. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-22236-8_7.
Pełny tekst źródłaAllmang, Christine, i Alain Krol. "Selenoprotein Biosynthesis". W Advanced Topics in Science and Technology in China, 107–24. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-22236-8_8.
Pełny tekst źródłaSchweizer, Ulrich. "Selenoprotein P". W Encyclopedia of Metalloproteins, 1942–48. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-1533-6_474.
Pełny tekst źródłaMoustafa, Mohamed E. "Selenoprotein K". W Encyclopedia of Metalloproteins, 1938–42. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-1533-6_499.
Pełny tekst źródłaTsuji, Petra A., i Bradley A. Carlson. "Selenoprotein Sep15". W Encyclopedia of Metalloproteins, 1948–52. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-1533-6_500.
Pełny tekst źródłaSunde, Roger A. "Regulation of selenoprotein expression". W Selenium, 81–96. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1609-5_8.
Pełny tekst źródłaStreszczenia konferencji na temat "Selenoprote"
Galinn, Sarah E., Lindsay C. Rosenthal, Steven M. Barsotti i Petra A. Tsuji. "Abstract 4881: Influence of polyphenols on selenoprotein expression in human colon cancer cells." W Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-4881.
Pełny tekst źródłaPenney, Kathryn L., Haojie Li, Lorelei A. Mucci, J. Steven Morris, Howard D. Sesso, Meir J. Stampfer i Jing Ma. "Abstract A122: Genetic variation in selenoprotein P, selenium levels, and prostate cancer risk and survival". W Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Dec 6–9, 2009; Houston, TX. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1940-6207.prev-09-a122.
Pełny tekst źródłaLin, Shih-Wen, Neal D. Freedman, Philip R. Taylor, You-Lin Qiao, Christian C. Abnet, Paula Hyland, Nan Hu i in. "Abstract A59: Selenoprotein gene variants and risk of esophageal and gastric cancer in a Chinese population". W Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Oct 22-25, 2011; Boston, MA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1940-6207.prev-11-a59.
Pełny tekst źródłaGopalakrishna, Rayudu, Jason E. Schiffman, Joshua Man, Lok Lei, Adela Wu i Usha Gundimeda. "Abstract 1889: Curcumin potentiates the cancer-preventive actions of selenium by inactivating selenoprotein thioredoxin reductase in prostate cancer cells". W Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1889.
Pełny tekst źródłaGopalakrishna, Rayudu, Jason Eric Schiffman, Kelley Mowatt i Usha Gundimeda. "Abstract 3687: Curcumin both inactivates and induces selenoprotein thioredoxin reductase: dual regulation influences curcumin-induced apoptosis in prostate cancer cells". W Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3687.
Pełny tekst źródłaAhmed, Elaf Husham, i Aseel Mokdad Hatam Abdul Wahed. "Evaluation of Fetuin A, Hepassocin, Selenoprotien P levels and number of biochemical variables in diabetes mellitus type 2 males’ patients". W FIFTH INTERNATIONAL CONFERENCE ON APPLIED SCIENCES: ICAS2023. AIP Publishing, 2024. http://dx.doi.org/10.1063/5.0211542.
Pełny tekst źródłaLi, Sharon, Paula L. Hyland, Neal D. Freedman, Nan Hu, Hua Su, Lemin Wang, Chaoyu Wang i in. "Abstract 2206: Genetic variants in selenoprotein genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population". W Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-2206.
Pełny tekst źródłaGopalakrishna, Rayudu, Barsegh A. Barseghian, Carleen Sarksian, Jason E. Schiffman, David V. Rayudu i Usha Gundimeda. "Abstract 3677: Prostate cancer progression decreases the cancer prevention by selenium: relation to overexpression of protein kinase Cε and selenoprotein thioredoxin reductase." W Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-3677.
Pełny tekst źródłaGopalakrishna, Rayudu, Venkata S. Arepalli, Albert Elhiani, Jason E. Schiffman i Usha Gundimeda. "Abstract 1609: Oxidation products of green tea polyphenols induce inactivation of PKC isoenzymes and induce cell death via modulation of selenoprotein thioredoxin reductase and quinone reductase". W Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-1609.
Pełny tekst źródła